Searchable abstracts of presentations at key conferences in endocrinology

ea0021cm3.3 | Management of congenital adrenal hyperplasia across the lifespan | SFEBES2009

The adult with CAH: results of the UK congenital adrenal hyperplasia, adult study executive (CaHASE)

Ross R J , Willis D S , Wild S H , Krone N , Doherty E J , Han T S , Carroll P V , Conway G S , Rees D A , Stimson R H , Walker B R , Connell J C , Arlt W

Background: No treatment guidelines exist for CAH adults. To address this we have undertaken a cross-sectional analysis of health status.Patients and methods: Three hundred and eighty patients from 17 tertiary centres were contacted: 203 (53%) consented (138 f, 65 m, median age 34 (range 18–69) years). One hundred and sixty-five had classic and 34 non-classic CAH. The UK prevalence is 3591 adults >18 years therefore the capture rate was 5.7%. Re...